clenbuterol has been researched along with Seizures in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol (0." | 1.36 | The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. ( Connor, TJ; Gleeson, LC; Griffin, EW; Harkin, A; Ryan, KJ, 2010) |
| "In the maximal electroshock seizure threshold test, clenbuterol (> or =4 mg/kg i." | 1.31 | Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol. ( Fischer, W; Kittner, H; Malinowska, B; Regenthal, R; Schlicker, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gleeson, LC | 1 |
| Ryan, KJ | 1 |
| Griffin, EW | 1 |
| Connor, TJ | 1 |
| Harkin, A | 1 |
| Fischer, W | 1 |
| Kittner, H | 1 |
| Regenthal, R | 1 |
| Malinowska, B | 1 |
| Schlicker, E | 1 |
2 other studies available for clenbuterol and Seizures
| Article | Year |
|---|---|
The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity.
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Anti-Inflammatory Agents; Apoptosis; Brain-Derived Neu | 2010 |
Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Anticonvulsants; Clenbuterol; Electroshock; Female; Hippocampus; | 2001 |